Maintain pressure on reforms to protect NHSBird flu vaccine approved
The European medicines watchdog has granted marketing authorisation for the first pre-pandemic bird flu vaccine.
Prepandrix, which contains inactivated H5N1 antigens, has been recommended by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
Pre-pandemic vaccines are prepared from influenza viruses with a pandemic potential and are intended for use before a pandemic is declared or during an officially declared pandemic.
The CHMP has also approved Pandemrix, a mock-up H5N1 influenza vaccine, for use during a pandemic. Both vaccines are manufactured by GlaxoSmithKline Biologicals SA.
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Share
Have your say
You must sign in to make a comment.